Kentaro Jingushi

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Kentaro Jingushi, Atsunari Kawashima, Sayaka Tanikawa, Takuro Saito, Akinaru Yamamoto, Toshihiro Uemura, Nesrine Sassi, Yu Ishizuya, Yoshiyuki Yamamoto, Taigo Kato, Koji Hatano, Hiroaki Hase, Norio Nonomura, Kazutake Tsujikawa
Cutibacterium acnes-derived extracellular vesicles promote tumor growth in renal cell carcinoma. Cancer science (2024)
Kentaro Jingushi, Atsunari Kawashima, Sayaka Tanikawa, Takuro Saito, Akinaru Yamamoto, Toshihiro Uemura, Nesrine Sassi, Yu Ishizuya, Yoshiyuki Yamamoto, Taigo Kato, Koji Hatano, Hiroaki Hase, Norio Nonomura, Kazutake Tsujikawa
Cutibacterium acnes-derived extracellular vesicles promote tumor growth in renal cell carcinoma. Cancer science 115 (8) (2024)
Kentaro Jingushi, Atsunari Kawashima, Sayaka Tanikawa, Takuro Saito, Akinaru Yamamoto, Toshihiro Uemura, Nesrine Sassi, Yu Ishizuya, Yoshiyuki Yamamoto, Taigo Kato, Koji Hatano, Hiroaki Hase, Norio Nonomura, Kazutake Tsujikawa
Cutibacterium acnes-derived extracellular vesicles promote tumor growth in renal cell carcinoma. Cancer science 115 (8) (2024)
Kentaro Jingushi, Atsunari Kawashima, Sayaka Tanikawa, Takuro Saito, Akinaru Yamamoto, Toshihiro Uemura, Nesrine Sassi, Yu Ishizuya, Yoshiyuki Yamamoto, Taigo Kato, Koji Hatano, Hiroaki Hase, Norio Nonomura, Kazutake Tsujikawa
Cutibacterium acnes-derived extracellular vesicles promote tumor growth in renal cell carcinoma. Cancer science 115 (8) (2024)
Yuya Monoe, Shunsuke Miyamoto, Kentaro Jingushi, Masaya Tanimoto, Tomohito Tanaka, Kohei Taniguchi, Kazumasa Komura, Masahide Ohmichi, Kazutake Tsujikawa
Hypoxia regulates tumour characteristic RNA modifications in ovarian cancers. The FEBS journal (2022)
Yuya Monoe, Kentaro Jingushi, Akitaka Kawase, Takayuki Hirono, Ryo Hirose, Yoshino Nakatsuji, Kaori Kitae, Yuko Ueda, Hiroaki Hase, Yuichi Abe, Jun Adachi, Takeshi Tomonaga, Kazutake Tsujikawa
Pharmacological Inhibition of miR-130 Family Suppresses Bladder Tumor Growth by Targeting Various Oncogenic Pathways via PTPN1. International journal of molecular sciences 22 (9) (2021)
Takuya Naito, Kentaro Jingushi, Koji Ueda, Kazutake Tsujikawa
Azurocidin is loaded into small extracellular vesicles via its N-linked glycosylation and promotes intravasation of renal cell carcinoma cells. FEBS letters 595 (19) (2021)
Takayuki Hirono, Kentaro Jingushi, Toshiyuki Nagata, Masami Sato, Kentaro Minami, Masaya Aoki, Aya Harada Takeda, Tadashi Umehara, Hiroshi Egawa, Yoshino Nakatsuji, Kaori Kitae, Yuko Ueda, Hiroaki Hase, Masatatsu Yamamoto, Yoshinari Shinsato, Kohichi Kawahara, Tatsuhiko Furukawa, Kazutake Tsujikawa
MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2. Scientific reports 9 (1) (2019)
Kyosuke Matsuzaki, Kazutoshi Fujita, Yujiro Hayashi, Makoto Matsushita, Satoshi Nojima, Kentaro Jingushi, Taigo Kato, Atsunari Kawashima, Takeshi Ujike, Akira Nagahara, Motohide Uemura, Ryoichi Imamura, Seiji Yamaguchi, Hiroaki Fushimi, Hiroshi Miyamoto, Eiichi Morii, Norio Nonomura
STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinoma. PloS one 13 (8) (2018)
Kentaro Jingushi, Motohide Uemura, Naomi Ohnishi, Wataru Nakata, Kazutoshi Fujita, Takuya Naito, Risa Fujii, Naomi Saichi, Norio Nonomura, Kazutake Tsujikawa, Koji Ueda
Extracellular vesicles isolated from human renal cell carcinoma tissues disrupt vascular endothelial cell morphology via azurocidin. International journal of cancer 142 (3) (2017)

Kentaro Jingushi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kentaro Jingushi